DSK Legal, TT&A, Shardul Amarchand Mangaldas & Co., And Indus Law Advised On Redcliffe Lab's Series C Fundraise

DSK Legal, TT&A, Shardul Amarchand Mangaldas & Co., and Indus Law Advised on Redcliffe Labs' Series C Fundraise

DSK Legal, TT&A, SAM, Indus Law Act on Redcliffe Labs Series C Fundraise by IFU, Leapfrog Investments, HealthQuad Fund, and Spark Growth Ventures. Redcliffe Labs Group raised its Series C round of funding, led by Danish Development Finance Institution (DFI), IFU (Investeringsfonden for Udviklingslande – The Investment Fund for Developing Countries), Leapfrog Investments, HealthQuad Fund, and Spark Growth Ventures.

Redcliffe Labs is an affordable and convenient omni-channel diagnostics service operating across 220 cities in India. The company facilitates at-home diagnostics for more than 3,600 medical tests through its network of over 2,000 collection centres, supported by 80+ state-of- the-art labs. 

DSK Legal Transaction Team: The DSK Legal team involved in negotiating and advising on the transaction documentation was led by Nakul Batra (Partner), along with Palak Sehgal (Principal Associate), Devbrat Singh (Senior Associate), Aankhi Anwesha (Associate), and Daksh Krishnan (Associate).

DSK Legal Due-Diligence Team: The DSK Legal team involved in conducting the vendor due diligence exercise comprised of Nakul Batra (Partner), Kunal Mehra (Partner), Prachi Gupta (Associate Partner), Palak Sehgal (Principal Associate), Danish Khan (Principal Associate), Aankhi Anwesha (Associate), Aakrit Aditya Sharma (Associate), and Daksh Krishnan (Associate). Suyash Srivastava (Partner) advised on the employment laws aspects of the due diligence, along with Prem Anand (Associate Partner) and Sachin Arora (Associate).

Redcliffe Lifetech Inc. (Delaware Corporation) was also supported by Bryan Cave Leighton Paisner (BCLP) in undertaking a limited due diligence from the perspective of applicable U.S laws.

Investor Counsels:

- IFU was represented by Talwar Thakore & Associates (TT&A)
- LeapFrog Investments was represented by Shardul Amarchand Mangaldas & Co. (SAM)
- Healthquad, Chiratae, Schroders, and Alkemi were represented by Indus Law (IL)
- Other Existing Investors were represented by their in-house legal teams

Deal Value: USD 42 million (~ INR 350 crores)